Literature DB >> 7488583

Effect of the cytokines on the prostaglandin E2 synthesis by lens epithelial cells of human cataracts.

O Nishi1, K Nishi, M Imanishi, Y Tada, E Shirasawa.   

Abstract

BACKGROUND: Lens epithelial cells (LECs) derived from human cataracts have been reported to produce various cytokines and prostaglandin E2 (PGE2) in culture. The effects of IL-1, TGF-beta, and b-FGF on the PGE2 synthesis by LECs have been studied.
METHODS: A circular piece of the anterior capsule with attached LECs was obtained by capsulotomy during cataract surgery and cultured. The primary, almost confluent, cultures were used for the study. The PGE2 concentration of the culture media for 24 h was measured after the addition of recombinant human IL-1 alpha, TGF-beta 2, or b-FGF at various concentrations. The PGE2 concentration was also measured in the media to which each cytokine and rabbit polyclonal anti-human antibodies against the corresponding cytokine had been added.
RESULTS: The PGE2 concentration of the culture media after addition of IL-1 alpha at the concentration of 100 or 500 pg/ml (1765 (768) and 3071 (1121) pg/10(4) cells) or TGF-beta 2 at the concentration of 10 or 100 ng/ml (689 (264) and 750 (189) pg/10(4) cells) was significantly increased compared with that in the controls (67 (20) pg/10(4) cells). These effects were suppressed by the corresponding anticytokine antibodies. Basic FGF and anti-human b-FGF showed no significant effect on the PGE2 concentration. IL-1 and TGF-beta increased but b-FGF did not affect the PGE2 synthesis by LECs in culture.
CONCLUSION: IL-1 and TGF-beta may participate in postoperative inflammation after cataract surgery by increasing PGE2 synthesis by residual LECs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488583      PMCID: PMC505296          DOI: 10.1136/bjo.79.10.934

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

1.  A molecule resembling fibroblast growth factor in aqueous humor.

Authors:  R C Tripathi; C B Millard; B J Tripathi; V Reddy
Journal:  Am J Ophthalmol       Date:  1988-08-15       Impact factor: 5.258

2.  Fibrinous membrane formation on the posterior chamber lens during the early postoperative period.

Authors:  O Nishi
Journal:  J Cataract Refract Surg       Date:  1988-01       Impact factor: 3.351

3.  Induction of cyclo-oxygenase by interleukin-1 in rheumatoid synovial cells.

Authors:  L A O'Neill; M L Barrett; G P Lewis
Journal:  FEBS Lett       Date:  1987-02-09       Impact factor: 4.124

4.  Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.

Authors:  W S Powell
Journal:  Prostaglandins       Date:  1980-11

5.  Interleukin-1 beta (IL-1 beta) modulates prostaglandin production and the natural IL-1 receptor antagonist inhibits ovulation in the optimally stimulated rat ovarian perfusion model.

Authors:  C M Peterson; H A Hales; H H Hatasaka; M D Mitchell; L Rittenhouse; K P Jones
Journal:  Endocrinology       Date:  1993-11       Impact factor: 4.736

6.  The role of arachidonic acid metabolism in the activities of interleukin 1 and 2.

Authors:  W L Farrar; J L Humes
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

7.  Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture.

Authors:  B A Jackson; R H Goldstein; R Roy; M Cozzani; L Taylor; P Polgar
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

8.  Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action.

Authors:  J Chang; S C Gilman; A J Lewis
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

9.  Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation.

Authors:  L T May; G Torcia; F Cozzolino; A Ray; S B Tatter; U Santhanam; P B Sehgal; D Stern
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

10.  Aspirin lowers blood pressure in patients with renovascular hypertension.

Authors:  M Imanishi; M Kawamura; S Akabane; Y Matsushima; M Kuramochi; K Ito; M Ohta; K Kimura; M Takamiya; T Omae
Journal:  Hypertension       Date:  1989-11       Impact factor: 10.190

View more
  6 in total

1.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

2.  Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta.

Authors:  S Ishizaka; M Kimoto; S Kanda; S Saito
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

3.  Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes.

Authors:  Hongling Liu; Lan Wu; Shaoying Fu; Yongsheng Hou; Ping Liu; Hao Cui; Jingjing Liu; Lin Xing; Xiaomei Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-09       Impact factor: 3.117

4.  Influence of cataract surgery and blood pressure changes caused by sodium restriction on retinal vascular diameter.

Authors:  Takatoshi Tano; Yoshimune Hiratsuka; Koichi Ono; Akira Murakami
Journal:  Clin Ophthalmol       Date:  2010-11-15

5.  A simple method for establishing adherent ex vivo explant cultures from human eye pathologies for use in subsequent calcium imaging and inflammatory studies.

Authors:  Sofija Andjelic; Xhevat Lumi; Zoltán Veréb; Natasha Josifovska; Andrea Facskó; Marko Hawlina; Goran Petrovski
Journal:  J Immunol Res       Date:  2014-09-04       Impact factor: 4.818

Review 6.  Inflammation and macular oedema after pars plana vitrectomy.

Authors:  Vito Romano; Martina Angi; Fabrizio Scotti; Renata del Grosso; Davide Romano; Francesco Semeraro; Paolo Vinciguerra; Ciro Costagliola; Mario R Romano
Journal:  Mediators Inflamm       Date:  2013-10-30       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.